Purpose: Screening for potentially inappropriate medications (PIM) is recommended in older patients with cancer receiving chemotherapy, given the concern for adverse drug reactions, drug-drug interactions and non-adherence. Our objective was to determine the impact of PIM on outcomes in patients with breast and colorectal cancers receiving chemotherapy.
Methods: We used data from the SEER-Medicare database, including patients >/= 66 years old with a diagnosis of Stage II/III breast and colorectal cancer made between 7/1/2007-12/31/2009. We used modified STOPP criteria to define baseline PIM as a dichotomous variable in the 4 months prior to diagnosis. STOPP criteria was used based on its performance as a robust measure of PIM. Outcomes measures included ER visits, hospitalizations, and death within 3 months from the last chemotherapy, and a composite of the three. We used Chi-square or Fisher's exact test to determine associations of PIM with covariates and outcomes, and Cox proportional hazards (PH) model for the time-to-event analysis.
Results: Final analysis included 1,595 patients with breast cancer and 1,528 patients with colorectal cancer. Frequency of baseline PIM by STOPP was 31.5% in the breast and 30.9% in the colorectal cohort. In the breast cohort, associations with the composite outcome in the Cox PH model included disease stage, comorbidity, medication number and baseline ER visits/hospitalization. Age, gender, race, comorbidity and baseline ER visits/hospitalization were associated in the colorectal cohort. PIM was not associated with outcomes in either cohort, aside from hospitalization in the breast.
Conclusions: We found no consistent association between pre-chemotherapy PIM defined by STOPP and outcomes.
Keywords: Breast cancer; Colorectal cancer; Geriatric oncology; Health outcomes; Inappropriate medications; Polypharmacy; STOPP criteria.
Copyright © 2019 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors have no conflict of interest to disclose.
Potentially inappropriate medication use in older patients with breast and colorectal cancer.Cancer. 2018 Jul 15;124(14):3000-3007. doi: 10.1002/cncr.31403. Epub 2018 Apr 24. Cancer. 2018. PMID: 29689595 Free PMC article.
Potentially Inappropriate Prescribing in Disabled Older Patients with Chronic Diseases: A Screening Tool of Older Persons' Potentially Inappropriate Prescriptions versus Beers 2012 Criteria.Med Princ Pract. 2015;24(6):565-70. doi: 10.1159/000435955. Epub 2015 Aug 1. Med Princ Pract. 2015. PMID: 26279164 Free PMC article.
Efficacy of pharmacists’ assessment and intervention based on Screening Tool for Older Persons’ Appropriate Prescriptions for Japanese compared with Screening Tool of Older Persons' potentially inappropriate Prescriptions criteria version 2 in older patients with cardiovascular disease.Geriatr Gerontol Int. 2019 Nov;19(11):1101-1107. doi: 10.1111/ggi.13773. Geriatr Gerontol Int. 2019. PMID: 31746526 Clinical Trial.
Effectiveness of the STOPP/START (Screening Tool of Older Persons' potentially inappropriate Prescriptions/Screening Tool to Alert doctors to the Right Treatment) criteria: systematic review and meta-analysis of randomized controlled studies.J Clin Pharm Ther. 2016 Apr;41(2):158-69. doi: 10.1111/jcpt.12372. Epub 2016 Mar 17. J Clin Pharm Ther. 2016. PMID: 26990017 Review.
STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progress.Expert Rev Clin Pharmacol. 2020 Jan;13(1):15-22. doi: 10.1080/17512433.2020.1697676. Epub 2019 Nov 30. Expert Rev Clin Pharmacol. 2020. PMID: 31790317 Review.
Cited by 1 article
Associations of Polypharmacy and Inappropriate Medications with Adverse Outcomes in Older Adults with Cancer: A Systematic Review and Meta-Analysis.Oncologist. 2020 Jan;25(1):e94-e108. doi: 10.1634/theoncologist.2019-0406. Epub 2019 Sep 30. Oncologist. 2020. PMID: 31570516 Free PMC article.